Global Depyrogenated Sterile Empty Vials Market by Type (Glass Vials, Plastic Vials), Capacity (10mL, 20mL, 2mL), End-User - Forecast 2024-2030

Report
182 Pages
June 2024
Region: Global
360iResearch™
ID: 5977973

The Depyrogenated Sterile Empty Vials Market size was estimated at USD 797.79 million in 2023, USD 846.93 million in 2024, and is expected to grow at a CAGR of 6.67% to reachUSD 1.25 billion by 2030.

These vials are sterilized to eliminate any living microbes and are primarily used in the medical and pharmaceutical industries to safely store and transport various liquids, such as drugs or vaccines, ensuring these substances remain uncontaminated and safe for use in medical and pharmaceutical applications. In labs, these vials are used for collecting and handling samples in a sterile environment, ensuring the test results are free from contaminants. In biotechnological and pharmaceutical research, these vials are essential for experiments that involve handling sensitive liquids requiring strict sterility to maintain the integrity of the results. With rising need for products that ensure the safe administration of medical treatments, driven by regulatory standards and healthcare policies that emphasize patient safety, the need for dehydrogenated sterile empty vials is also increasing. However, the risk associated with the availability of counterfeit products hinders the growth of the dehydrogenated sterile empty vials market. Moreover, the advancements in sterilization and depyrogenation technologies enhance the safety and efficiency of the vials and offer more sustainable pharmaceutical production practices thus increasing the need for depyrogenated sterile empty vials globally.

Regional Insights

In the Americas, particularly in the United States and Canada, there is a robust need for depyrogenated sterile empty vials, supported by a well-established pharmaceutical and biotechnology sector. The increasing emphasis on safety and sterility in drug manufacturing processes primarily drives the need. The growing stringent regulations in the United States regarding drug safety, enforced by the FDA, mandate the use of dehydrogenated vials to minimize the risk of pyrogen contamination in injectable drugs. Increased research and development activities and regional clinical trials contribute significantly to market growth. In the Asia Pacific, countries such as China, India, and Japan are experiencing rapid growth in the healthcare sector, augmented by increasing investments in healthcare infrastructure and a growing focus on local manufacturing of pharmaceuticals. The rising prevalence of chronic diseases and a booming generic drugs market particularly in India, require stringent adherence to contamination-free drug delivery systems, thereby driving the need for depyrogenated sterile empty vials. Expansion of pharmaceutical manufacturing and an increase in export of drugs necessitate adherence to international quality standards, acting as another key driver for the depyrogenated sterile empty vials market. Europe has a well-established pharmaceutical market, with advanced healthcare systems and a strong focus on research and innovation. Strict EU regulations on pharmaceutical manufacturing and drug safety standards necessitate the use of depyrogenated sterile empty vials, especially for injectable medicines. The presence of numerous pharmaceutical companies and a sophisticated healthcare infrastructure supports the use of these vials. In the Middle East and Africa, increases in healthcare expenditure, the establishment of new pharmaceutical plants, and government initiatives to boost the healthcare sector are enhancing the need for these vials.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Depyrogenated Sterile Empty Vials Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Increased demand from pharmaceutical and biotechnology industries
Growing initiatives from government and private organizations to advance vaccination

Market Restraints

Lack of healthcare infrastructure

Market Opportunities

Advancements in sterilization and depyrogenation technologies
Enhanced Focus on Specialized Packaging for depyrogenated sterile empty vials

Market Challenges

Risks associated with counterfeit products

Market Segmentation Analysis

Type: Expanding use of plastic vials due to their cost effective nature
End-user: proliferating use of depyrogenated sterile empty vials in clinical research

Industry Insights

Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Depyrogenated Sterile Empty Vials Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Depyrogenated Sterile Empty Vials Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

ALK Life Science Solutions Forms Strategic Partnership with Galenova for Distribution of Depyrogenated Sterile Empty Vials

ALK Life Science Solutions entered into a distribution agreement with Galenova, a key distributor in the Canadian market. The partnership aims to leverage Galenova’s robust distribution network across Canada, ensuring an efficient and reliable supply of these essential vials to meet the growing demands of healthcare and scientific research. This collaboration marks a significant step for ALK Life Science Solutions in expanding its market presence and supporting healthcare providers with high-quality, specialized pharmaceutical supplies.

Corning and SGD Pharma Forge Strategic Alliance with New Glass Tubing Facility

Corning Incorporated and SGD Pharma announced the creation of a joint venture that includes the launch of an advanced glass tubing facility. The collaboration aims to enhance the production capabilities of high-quality pharmaceutical glass tubing, which is crucial for making vials and other containers that meet the stringent sterility standards required by the healthcare industry. The new facility is expected to be pivotal in improving the supply chain efficiency for sterile and depyrogenated vials, contributing to safer and more effective drug delivery systems.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Depyrogenated Sterile Empty Vials Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Depyrogenated Sterile Empty Vials Market, highlighting leading vendors and their innovative profiles. These include Arab Pharmaceutical Glass Co. (APG), Bormioli Pharma, Consol Glass, Corning Inc., Gerresheimer AG, Global Pharmatech Pvt. Ltd., Hindusthan National Glass & Industries Ltd., Nipro Corporation, Piramal Glass, SCHOTT AG, SGD Pharma, SGD S.A.S, Shandong Pharmaceutical Glass Co., Ltd., Stevanato Group, Thermo Fisher Scientific Inc., Triveni Polymers Pvt. Ltd., West Pharmaceutical Services, Inc., and YPSOMED AG.

Market Segmentation & Coverage

This research report categorizes the Depyrogenated Sterile Empty Vials Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type

Glass Vials
Plastic Vials

Capacity

10mL
20mL
2mL
5mL

End-User

Healthcare Institutions
Pharmaceutical Companies
Research & Academic Labs

Region

Americas

Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific

Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa

Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Additional Product Information:

The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
Purchase of this report includes 1 year online access with quarterly updates
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased demand from pharmaceutical and biotechnology industries
5.1.1.2. Growing initiatives from government and private organizations to advance vaccination
5.1.2. Restraints
5.1.2.1. Lack of healthcare infrastructure
5.1.3. Opportunities
5.1.3.1. Advancements in sterilization and depyrogenation technologies
5.1.3.2. Enhanced Focus on Specialized Packaging for depyrogenated sterile empty vials
5.1.4. Challenges
5.1.4.1. Risks associated with counterfeit products
5.2. Market Segmentation Analysis
5.2.1. Type: Expanding use of plastic vials due to their cost effective nature
5.2.2. End-user: proliferating use of depyrogenated sterile empty vials in clinical research
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Depyrogenated Sterile Empty Vials Market, by Type

6.1. Introduction
6.2. Glass Vials
6.3. Plastic Vials

7. Depyrogenated Sterile Empty Vials Market, by Capacity

7.1. Introduction
7.2. 10mL
7.3. 20mL
7.4. 2mL
7.5. 5mL

8. Depyrogenated Sterile Empty Vials Market, by End-User

8.1. Introduction
8.2. Healthcare Institutions
8.3. Pharmaceutical Companies
8.4. Research & Academic Labs

9. Americas Depyrogenated Sterile Empty Vials Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Depyrogenated Sterile Empty Vials Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Depyrogenated Sterile Empty Vials Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. ALK Life Science Solutions Forms Strategic Partnership with Galenova for Distribution of Depyrogenated Sterile Empty Vials
12.3.2. Corning and SGD Pharma Forge Strategic Alliance with New Glass Tubing Facility
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio

List of Figures

FIGURE 1. DEPYROGENATED STERILE EMPTY VIALS MARKET RESEARCH PROCESS
FIGURE 2. DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DEPYROGENATED STERILE EMPTY VIALS MARKET DYNAMICS
FIGURE 7. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. DEPYROGENATED STERILE EMPTY VIALS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. DEPYROGENATED STERILE EMPTY VIALS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. DEPYROGENATED STERILE EMPTY VIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 10ML, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 20ML, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 20ML, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 2ML, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY 5ML, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HEALTHCARE INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH & ACADEMIC LABS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH & ACADEMIC LABS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 51. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 52. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 53. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 54. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 55. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 56. CANADA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 57. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 58. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 59. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 60. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 61. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 62. MEXICO DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 83. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 84. AUSTRALIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 85. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 86. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 87. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 88. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 89. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 90. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 91. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 92. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 93. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 94. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 95. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 96. INDIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 101. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 102. INDONESIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 103. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 104. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 105. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 106. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 107. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 108. JAPAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 113. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 114. MALAYSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 119. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 120. PHILIPPINES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 125. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 126. SINGAPORE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 131. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 132. SOUTH KOREA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 137. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 138. TAIWAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 139. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 140. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 141. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 142. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 143. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 144. THAILAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 149. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 150. VIETNAM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 159. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 160. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 161. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 162. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 163. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 164. DENMARK DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 165. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 166. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 167. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 168. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 169. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 170. EGYPT DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 171. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 174. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 175. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 176. FINLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 177. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 178. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 179. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 180. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 181. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 182. FRANCE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 183. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 184. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 185. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 186. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 187. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 188. GERMANY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 193. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 194. ISRAEL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 195. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 196. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 197. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 198. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 199. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 200. ITALY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 205. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 206. NETHERLANDS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 211. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 212. NIGERIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 213. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 214. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 215. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 216. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 217. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 218. NORWAY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 219. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 220. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 221. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 222. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 223. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 224. POLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 225. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 226. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 227. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 228. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 229. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 230. QATAR DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 235. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 236. RUSSIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 242. SAUDI ARABIA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 248. SOUTH AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 249. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 250. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 251. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 252. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 253. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 254. SPAIN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 259. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 260. SWEDEN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 265. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 266. SWITZERLAND DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 267. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 268. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 269. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 270. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 271. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 272. TURKEY DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2024-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 284. UNITED KINGDOM DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 285. DEPYROGENATED STERILE EMPTY VIALS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 286. DEPYROGENATED STERILE EMPTY VIALS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

Arab Pharmaceutical Glass Co. (APG)
Bormioli Pharma
Consol Glass
Corning Inc.
Gerresheimer AG
Global Pharmatech Pvt. Ltd.
Hindusthan National Glass & Industries Ltd.
Nipro Corporation
Piramal Glass
SCHOTT AG
SGD Pharma
SGD S.A.S
Shandong Pharmaceutical Glass Co., Ltd.
Stevanato Group
Thermo Fisher Scientific Inc.
Triveni Polymers Pvt. Ltd.
West Pharmaceutical Services, Inc.
YPSOMED AG

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	182
Published	June 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 846.93 Million
Forecasted Market Value ( USD ) by 2030	$ 1253.88 Million
Compound Annual Growth Rate	6.6%
Regions Covered	Global
No. of Companies Mentioned	18

PURCHASE OPTIONS

Single User License PDF, Excel And Online Access

1 - 5 User License PDF, Excel And Online Access

Enterprise License PDF, Excel And Online Access

need a quote ?

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3755EUR$3,939USD£3,169GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€4717EUR$4,949USD£3,982GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6643EUR$6,969USD£5,607GBP